The histone deacetylase inhibitor trichostatin (TSA) induces neutrophil differentiation in 32D cells over-expressing AML1, but not in cells expressing either AML1-ETO or AML1-MDS genes.

被引：0
|
作者：
Mills, KI
Walsh, V
Darley, RL
Gilkes, AF
Dann, EJ
Burnett, AK
机构：
[1] Univ Wales Coll Med, Cardiff CF4 4XN, S Glam, Wales
[2] Rambam Med Ctr, Haifa, Israel
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
523
引用
收藏
页码：122A / 122A
页数：1
相关论文
共 31 条
  • [21] Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3
    Liu, Yulin
    Zheng, Liting
    Li, Ying
    Ma, Lan
    Zheng, Nan
    Liu, Xinhua
    Zhao, Yanli
    Yu, Li
    Liu, Ning
    Liu, Shuangwei
    Zhang, Kun
    Zhou, Jingfeng
    Wei, Mingming
    Yang, Cheng
    Yang, Guang
    CANCER LETTERS, 2024, 594
  • [22] N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene
    Chou, Fu-Sheng
    Wunderlich, Mark
    Griesinger, Andrea
    Mulloy, James C.
    BLOOD, 2011, 117 (07) : 2237 - 2240
  • [23] Preleukemic AML1/ETO-expressing hematopoietic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation; Evidence for multistep leukemogenesis.
    Miyamoto, T
    Weissman, IL
    Akashi, K
    BLOOD, 1999, 94 (10) : 691A - 691A
  • [24] Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2
    Kohzaki, H
    Ito, K
    Huang, G
    Wee, HJ
    Murakami, Y
    Ito, Y
    ONCOGENE, 1999, 18 (28) : 4055 - 4062
  • [25] Arsenic trioxide (ATO) downregulates the expression of the AML1/MDS1/EVI-1 (AME) oncoprotein and induces differentiation and apoptosis in AME-leukemic cells
    Shackelford, D
    Waxman, S
    Ren, RB
    BLOOD, 2004, 104 (11) : 199B - 199B
  • [26] Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2
    Hidetsugu Kohzaki
    Kosei Ito
    Gang Huang
    Hee-Jun Wee
    Yota Murakami
    Yoshiaki Ito
    Oncogene, 1999, 18 : 4055 - 4062
  • [27] THE THROMBOPOIETIN/C-MPL PATHWAY IS REQUIRED IN AML1-ETO EXPRESSING HUMAN HEMATOPOIETIC CD34+CELLS TO PROMOTE SELF-RENEWAL AND TO PREVENT APOPTOSIS
    Chou, F. C.
    Wunderlich, M. W.
    Mulloy, J. C.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S49 - S49
  • [28] The histone deacetylase inhibitor trichostatin A (TSA) potentiates 1,25 dihydroxy vitamin D3 (1,25 D3)-induced monocytic differentiation in human leukemic cells.
    Liou, R
    Stone, RM
    BLOOD, 1999, 94 (10) : 308A - 308A
  • [29] Superior Efficacy of Co-treatment with NPM1 Antagonist and FLT3 Inhibitor or Pan-histone Deacetylase Inhibitor Against Cultured and Primary Human AML Cells Co-expressing Mutant NPM1 and FLT3-ITD
    Balusu, R.
    Huffman, N.
    Fiskus, W.
    Smith, J.
    Peth, K.
    Hembruff, S.
    Rao, R.
    Ganguly, S.
    McGuirk, J.
    Bhalla, K. N.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 159 - 159
  • [30] MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells
    Nishioka, Chie
    Ikezoe, Takayuki
    Yang, Jing
    Takeuchi, Seisho
    Koeffler, H. Phillip
    Yokoyama, Akihito
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1382 - 1392
1234